Τρίτη 3 Μαρτίου 2020


Study to Evaluate the Efficacy and Safety of SHR6390 Combined With Pyrotinib in HER2+ Advanced Breast Cancer
Condition:   Metastatic Breast Cancer Interventions:   Drug: Pyrotinib;   Drug: SHR6390 Sponsors:   Henan Cancer Hospital;   Jiangsu HengRui Medicine Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.
MedWorm Cancer & Oncology Clinical Trials
Tue Mar 03, 2020 18:00
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Condition:   Acute Myeloid Leukemia Interventions:   Procedure: Allogeneic Hematopoietic Stem Cell Transplantation;   Drug: Asparaginase;   Drug: Asparaginase Erwinia chrysanthemi;   Behavioral: Cogstate Assessment Battery;   Drug: Cytarabine;   Drug: Daunorubicin;   Drug: Daunorubicin Hydrochloride;   Drug: Dexrazoxane;   Drug : Dexrazoxane Hydrochloride;   Drug: Etoposide;   Drug: Gemtuzumab Ozogamicin;   Drug: Gilteritinib;   Drug: Gilteritinib Fumarate;   Drug: Liposome-encapsulated Daunorubicin-Cytarabine;...
MedWorm Cancer & Oncology Clinical Trials
Tue Mar 03, 2020 18:00
Clinical Study of DC-CIK Cells as a Post-remission Treatment for Malignant Tumors
Condition:   Malignant Neoplasm Interventions:   Drug: Decitabine;   Biological: DC-CIK Sponsor:   Li Yu Recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Tue Mar 03, 2020 18:00
A Study of Select Drug Combinations in Adult Patients With Advanced/Metastatic BRAF V600 Colorectal Cancer
Condition:   BRAF V600 Colorectal Cancer Interventions:   Drug: Dabrafenib;   Drug: LTT462;   Drug: Trametinib;   Drug: LXH254;   Drug: TNO155;   Biological: Spartalizumab Sponsor:   Novartis Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.
MedWorm Cancer & Oncology Clinical Trials
Tue Mar 03, 2020 18:00
Development and Analysis of a Stool Bank for Cancer Patients
Conditions:   Carcinoma, Non-Small-Cell Lung;   Carcinoma, Colorectal Intervention:   Drug: Pembrolizumab Injection Sponsors:   Persephone Biosciences;   Pharm-Olam International Recruiting (Source: ClinicalTrials.gov)MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.
MedWorm Cancer & Oncology Clinical Trials
Mon Mar 02, 2020 18:00
a Vigibase Pharmacovigilance Study of ENzalutamide Drug-induced neurotoxicitY
Conditions:   Prostate Cancer;   Neuropathy;   Epilepsy;   Encephalopathy Intervention:   Drug: Enzalutamide Sponsor:   Groupe Hospitalier Pitie-Salpetriere Active, not recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Mon Mar 02, 2020 18:00
Fasting Mimicking Diet in Prostate Cancer and Metabolic Syndrome
Conditions:   Prostate Cancer;   Metabolic Syndrome;   Intermittent Fasting Intervention:   Other: Fasting mimicking diet Sponsor:   Galway Clinic Active, not recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Mon Mar 02, 2020 18:00
Preoperative Biliary Drainage in Patients With Operable Malignant Periampulary Tumors
Conditions:   Periampullary Cancer;   Biliary Obstruction;   Preoperative Biliary Drainage Interventions:   Procedure: Preoperative Biliary Drainage (PBD);   Procedure: Surgery Sponsor:   University of Alexandria Completed (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Mon Mar 02, 2020 18:00
Epigenetics of TNBC in Overweight and Obese Hispanic & Non-Hispanic White Women
Condition:   Triple Negative Breast Cancer Intervention:   Procedure: Needle core biopsy Sponsor:   University of Arizona Not yet recruiting (Source: ClinicalTrials.gov)MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.
MedWorm Cancer & Oncology Clinical Trials
Mon Mar 02, 2020 18:00
Lutetium-177-PSMA Radioligand Therapy in Advanced Salivary Gland Cancer Patients
Conditions:   Salivary Gland Cancer;   Salivary Duct Carcinoma;   Adenoid Cystic Carcinoma Intervention:   Drug: Lutetium-177-PSMA-I&T Sponsors:   Radboud University;   Dutch Cancer Society Not yet recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Mon Mar 02, 2020 18:00
A Multicenter Expanded Access Treatment Protocol of Lurbinectedin in Previously Treated SCLC in the USA
Condition:   Small Cell Lung Cancer Intervention:   Drug: Lurbinectedin Sponsors:   PharmaMar;   Bionical Emas Available (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Mon Mar 02, 2020 18:00
Intratympanic N-Acetylcysteine for Prevention of Cisplatin-induced Ototoxicity.
Condition:   Ototoxic Hearing Loss Intervention:   Drug: N-Acetyl Cysteine Sponsors:   Sunnybrook Health Sciences Centre;   Toronto Sunnybrook Regional Cancer Centre;   London Regional Cancer Program, Canada Recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Mon Mar 02, 2020 18:00
Immunotherapy Merkel Adjuvant Trial
Conditions:   Merkel Cell Carcinoma;   Merkel Cell Carcinoma, Stage I;   Merkel Cell Carcinoma, Stage II;   Merkel Cell Carcinoma, Stage III;   Neuroendocrine Tumors;   Carcinoma Neuroendocrine Skin Interventions:   Drug: Avelumab;   Drug: Placebo Sponsor:   Melanoma and Skin Cancer Trials Limited Not yet recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Mon Mar 02, 2020 18:00
Endometrial Cancer Conservative Treatment (E.C.Co). A Multicentre Archive
Condition:   Endometrial Cancer Intervention:   Other: Data collection Sponsor:   National Cancer Institute, Naples Recruiting (Source: ClinicalTrials.gov)MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.
MedWorm Cancer & Oncology Clinical Trials
Mon Mar 02, 2020 18:00
Oxaloacetate for the Improvement of Cognitive Complaints in Stage 0-IIIA Breast Cancer Survivors
Conditions:   Anatomic Stage 0 Breast Cancer AJCC v8;   Anatomic Stage I Breast Cancer AJCC v8;   Anatomic Stage IA Breast Cancer AJCC v8;   Anatomic Stage IB Breast Cancer AJCC v8;   Anatomic Stage II Breast Cancer AJCC v8;   Anatomic Stage IIA Breast Cancer AJCC v8;   Anatomic Stage IIB Breast Cancer AJCC v8;   Anatomic Stage IIIA Breast Cancer AJCC v8;   Early-Stage Breast Carcinoma;   Prognostic Stage 0 Breast Cancer AJCC v8;   Prognostic Stage I Breast Cancer AJCC v8;   Prognostic Stage IA Breast Cancer AJCC v8;...
MedWorm Cancer & Oncology Clinical Trials
Mon Mar 02, 2020 18:00
PK and Dose Escalation and Expansion Study of DST-2970
Condition:   Prostate Cancer Interventions:   Drug: Abiraterone Acetate;   Drug: Prednisone 5Mg Tab;   Drug: DST-2970 (Abiraterone) Sponsors:   DisperSol Technologies, LLC;   Translational Drug Development Recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Mon Mar 02, 2020 18:00
UCSF Panc Cyst Registry
Conditions:   Pancreatic Cyst;   Pancreatic Neoplasms;   Pancreatic Cancer;   Pancreatic Diseases;   Pancreatic IPMN;   IPMN;   Pancreatic Ductal Adenocarcinoma;   Mucinous Cyst Intervention:   Other: Survey Sponsors:   University of California, San Francisco;   Eureka Recruiting (Source: ClinicalTrials.gov)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.
MedWorm Cancer & Oncology Clinical Trials
Mon Mar 02, 2020 18:00
Dose Reduction of Postoperative Radiation for Soft Tissue Sarcoma of the Arms and Legs
Condition:   Soft Tissue Sarcoma Intervention:   Radiation: Intensity-modulated radiation therapy (IMRT) Sponsors:   Memorial Sloan Kettering Cancer Center;   National Institutes of Health (NIH) Recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Mon Mar 02, 2020 18:00
Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease
Conditions:   Endometrial Cancer;   Endometrioid Adenocarcinoma;   Endometrial Cancer Stage I Intervention:   Other: Physical exam Sponsor:   Memorial Sloan Kettering Cancer Center Recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Mon Mar 02, 2020 18:00
Split-course SBRT for Borderline Resectable and Locally Advanced Pancreatic Cancer
Condition:   Pancreatic Neoplasms Interventions:   Drug: nab-Paclitaxel+Gemcitabine;   Radiation: split-course SBRT Sponsor:   Fujian Medical University Union Hospital Recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Mon Mar 02, 2020 18:00
The DBCG Proton Trial: Photon Versus Proton Radiation Therapy for Early Breast Cancer
Conditions:   Early Breast Cancer;   Radiation Associated Cardiac Failure Intervention:   Radiation: Proton versus photon radiation therapy Sponsor:   Danish Breast Cancer Cooperative Group Not yet recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Mon Mar 02, 2020 18:00
Predicted Biomarkers of CDK4/6 Inhibitors (Palbociclib) in ER-positive Metastasis Breast Cancer
Condition:   Breast Cancer Intervention:   Drug: Palbociclib Sponsors:   Chinese Academy of Medical Sciences;   OrigiMed Recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Mon Mar 02, 2020 18:00
CIML NK Cell in Head & Neck Cancer
Conditions:   Squamous Cell Carcinoma of the Head and Neck;   Recurrent Head and Neck Squamous Cell Carcinoma Interventions:   Drug: Interleukin-15 Superagonist (N-803);   Biological: CIML NK cell Infusion;   Drug: Ipilimumab Sponsors:   Dana-Farber Cancer Institute;   Altor BioScience;   Bristol-Myers Squibb;   Miltenyi Biotec B.V. & Co. KG Not yet recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Mon Mar 02, 2020 18:00
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients
Conditions:   Melanoma;   Hepatocellular Carcinoma;   Non Small Cell Lung Cancer;   Endometrial Cancer Interventions:   Biological: VV1;   Biological: Cemiplimab Sponsors:   Vyriad, Inc.;   Regeneron Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Mon Mar 02, 2020 18:00
Registry Platform Gastric/Esophageal Cancer (SAPHIR)
Conditions:   Esophageal Cancer;   Gastric Cancer;   Gastroesophageal Junction Adenocarcinoma Intervention:   Other: Routine care as per site standard Sponsor:   iOMEDICO AG Recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Mon Mar 02, 2020 18:00
SRK-181 Alone or in Combination With Anti-PD-(L)1 Antibody Therapy in Patients With Locally Advanced or Metastatic Solid Tumors
Condition:   Cancer Interventions:   Biological: SRK-181;   Biological: anti-PD-(L)1 antibody therapy Sponsor:   Scholar Rock, Inc. Not yet recruiting (Source: ClinicalTrials.gov)MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.
MedWorm Cancer & Oncology Clinical Trials
Mon Mar 02, 2020 18:00
Web-Based Lifestyle Intervention for the Improvement of Health in African American Cancer Survivors
Condition:   Cancer Survivor Interventions:   Behavioral: Lifestyle Therapy;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration Sponsors:   Roswell Park Cancer Institute;   National Cancer Institute (NCI) Recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Mon Mar 02, 2020 18:00
Lorlatinib Combinations in Lung Cancer
Conditions:   Lung Cancer;   Anaplastic Lymphoma Kinase Gene Translocation;   ROS1 Rearrangement;   Relapsed Cancer;   MET Amplification;   Resistant Cancer Interventions:   Drug: Lorlatinib;   Drug: Crizotinib;   Drug: Binimetinib Sponsors:   Massachusetts General Hospital;   Array BioPharma;   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Mon Mar 02, 2020 18:00
Neoadjuvant Chemotherapy With Pyrotinib, Epirubicin and Cyclophosphamide Followed by Taxanes and Trastuzumab for HER-2+ Breast Cancer
Condition:   Breast Cancer Interventions:   Drug: Pyrotinib;   Drug: Epirubicin;   Drug: Cyclophosphamide;   Drug: Taxanes;   Biological: Trastuzumab Sponsor:   Hebei Medical University Fourth Hospital Not yet recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Mon Mar 02, 2020 18:00
Dynamic Neural Mechanisms of Audiovisual Speech Perception
Condition:   Speech Perception Intervention:   Other: Measurement of brain activity using electrodes. Sponsors:   Baylor College of Medicine;   Columbia University;   M.D. Anderson Cancer Center Enrolling by invitation (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Mon Mar 02, 2020 18:00
Systematic Radioiodine Administration (3.7 GBq I131 After rhTSH) Versus Decision of Radioiodine Treatment Guided by a Post-operative Work-up
Conditions:   Thyroid Cancer;   Intermediate Risk Interventions:   Drug: Systematic RAI-treatment;   Other: Decision of RAI-treatment guided by a post-operative assessment Sponsors:   Centre Francois Baclesse;   French cancer Institute INCa Not yet recruiting (Source: ClinicalTrials.gov)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.
MedWorm Cancer & Oncology Clinical Trials
Mon Mar 02, 2020 18:00

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου